HRT risk is a developing story, confounded by different
Breast cancer risk - calculated variations in absolute risk based on metadata analysis
|Age at calculation||% risk with no HRT||3 years combination HRT||5 years combination HRT||10 years combination HRT||15 years combination HRT||3 years oestrogen only HRT||5 years oestrogen only HRT||10 years oestrogen only HRT||15 years oestrogen only HRT|
Hormone therapy for menopausal symptoms (2012): the increased risk of breast cancer associated with use of combined oestrogen-progestogen (hazard ratio 1.24) is similar to risks conferred by delayed menopause or moderate use of alcohol.
Estimated benefits and risks of oral HRT in postmenopausal women aged 50-59 years, or <10 years after menopause (2012)
Hormone replacement therapy (2012)